Concomitant t(8;21) and trisomy 4 in a patient with Acute Myeloid Leukemia (AML)
The t(8;21)(q22;q22) is a frequently occurring aberration in acute myeloid leukemia (AML) (18-20%) and usually correlate with French-America-British (FAB) M2 subtype. Several studies showed that patients carrying this abnormality demonstrated good response to standard chemotherapy but also have a...
Main Authors: | Phan CL, Ong TC, Chang KM, Zubaidah Z, Puteri Jamilatul NMB |
---|---|
Format: | Article |
Language: | English |
Published: |
Penerbit UKM
2010
|
Online Access: | http://journalarticle.ukm.my/2079/1/08MS090_4144.pdf |
Similar Items
-
Clinical, Cytogenetic, and Molecular Findings in Two Cases of Variant t(8;21) Acute Myeloid Leukemia (AML)
by: Lindsay Wilde, et al.
Published: (2019-10-01) -
Successful Outcome of a Case of Acute Myeloid Leukemia with t(8;21)/AML-ETO Following Langerhans Cell Histiocytosis
by: Guangqiang Meng, et al.
Published: (2019-11-01) -
Leucemia mieloide aguda subtipo M2 con variante de la translocación t(8;21) y expresión AML1/ETO Acute myeloid leukemia (aml) subtype M2 with variation of the t (8;21)translocation and AML1/ETO expression
by: Yesica Llimpe, et al.
Published: (2013-03-01) -
Clinical and genetic characteristics of acute myeloid leukemia with t(8;21) in children and results of therapy according to protocol AML-MM-2000
by: I. I. Kalinina, et al.
Published: (2014-07-01) -
Clinical and genetic characteristics of acute myeloid leukemia with t(8;21) in children and results of therapy according to protocol AML-MM-2000
by: I. I. Kalinina, et al.
Published: (2014-07-01)